01548.HK
Genscript Biotech Corporation
HKSE · Healthcare · Biotechnology · CN
HKD 31.46
−13.33%Margins
Gross margin
53.7%
EBITDA margin
26.1%
EBIT margin
18.2%
Net margin
148.0%
FCF margin
14.5%
63.7%
Return on equity
51.7%
Return on assets
7.4%
Return on invested capital
0.35x
Asset turnover
HKD 2.6B
Cash from operations
HKD 2.97
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026